Proposing Magnetic Nanoparticle Hyperthermia in Low-Field MRI

Typeset version

 

TY  - JOUR
  - P. Cantillon-Murphy, L.L. Wald and E. Adalsteinsson
  - 2010
  - January
  - Concepts in Magnetic Resonance Part A
  - Proposing Magnetic Nanoparticle Hyperthermia in Low-Field MRI
  - Published
  - ()
  - 36A
  - 36
  - 47
  - This work examines feasibility, practical advantages, and disadvantages of a combined MRI/magnetic particle hyperthermia (MPH) system for cancerous tumor treatment in low perfusion tissue. Although combined MRI/hyperthermia systems have been proposed and constructed, the current proposal differs because the hyperthermia system would be specifically designed to interact with the magnetic nanoparticles injected at the tumor site. The proposal exploits the physical similarities between the magnetic nanoparticles currently employed for MPH and those used as superparamagnetic iron oxide (SPIO) contrast agents in MR imaging. The proposal involves the addition of a rotating magnetic field RF hyperthermia source perpendicular to the MRI B0 field which operates in a similar manner to the MRI RF excitation field, B1, but at significantly higher frequency and field strength such that the magnetic nanoparticles are forced to rotate in its presence. This rotation is the source of increases in temperature which are of therapeutic benefit in cancer therapy. For rotating magnetic fields with amplitudes much smaller than B0, the nanoparticles' suspension magnetization rapidly saturates with increasing B0. Therefore, the proposal is best suited to low-field MRI systems when magnetic saturation is incomplete. In addition, careful design of the RF hyperthermia source is required to ensure no physical or RF interference with the B1 field used for MRI excitation. Notwithstanding these caveats, the authors have shown that localized steady-state temperature rises in small spherical tumors of up to 10°C are conceivable with careful selection of the nanoparticle radius and concentration, RF hyperthermia field amplitude and frequency.
  - http://onlinelibrary.wiley.com/doi/10.1002/cmr.a.20153/abstract
DA  - 2010/01
ER  - 
@article{V73897478,
   = {P. Cantillon-Murphy, L.L. Wald and E. Adalsteinsson},
   = {2010},
   = {January},
   = {Concepts in Magnetic Resonance Part A},
   = {Proposing Magnetic Nanoparticle Hyperthermia in Low-Field MRI},
   = {Published},
   = {()},
   = {36A},
  pages = {36--47},
   = {{This work examines feasibility, practical advantages, and disadvantages of a combined MRI/magnetic particle hyperthermia (MPH) system for cancerous tumor treatment in low perfusion tissue. Although combined MRI/hyperthermia systems have been proposed and constructed, the current proposal differs because the hyperthermia system would be specifically designed to interact with the magnetic nanoparticles injected at the tumor site. The proposal exploits the physical similarities between the magnetic nanoparticles currently employed for MPH and those used as superparamagnetic iron oxide (SPIO) contrast agents in MR imaging. The proposal involves the addition of a rotating magnetic field RF hyperthermia source perpendicular to the MRI B0 field which operates in a similar manner to the MRI RF excitation field, B1, but at significantly higher frequency and field strength such that the magnetic nanoparticles are forced to rotate in its presence. This rotation is the source of increases in temperature which are of therapeutic benefit in cancer therapy. For rotating magnetic fields with amplitudes much smaller than B0, the nanoparticles' suspension magnetization rapidly saturates with increasing B0. Therefore, the proposal is best suited to low-field MRI systems when magnetic saturation is incomplete. In addition, careful design of the RF hyperthermia source is required to ensure no physical or RF interference with the B1 field used for MRI excitation. Notwithstanding these caveats, the authors have shown that localized steady-state temperature rises in small spherical tumors of up to 10°C are conceivable with careful selection of the nanoparticle radius and concentration, RF hyperthermia field amplitude and frequency.}},
   = {http://onlinelibrary.wiley.com/doi/10.1002/cmr.a.20153/abstract},
  source = {IRIS}
}
AUTHORSP. Cantillon-Murphy, L.L. Wald and E. Adalsteinsson
YEAR2010
MONTHJanuary
JOURNAL_CODEConcepts in Magnetic Resonance Part A
TITLEProposing Magnetic Nanoparticle Hyperthermia in Low-Field MRI
STATUSPublished
TIMES_CITED()
SEARCH_KEYWORD
VOLUME36A
ISSUE
START_PAGE36
END_PAGE47
ABSTRACTThis work examines feasibility, practical advantages, and disadvantages of a combined MRI/magnetic particle hyperthermia (MPH) system for cancerous tumor treatment in low perfusion tissue. Although combined MRI/hyperthermia systems have been proposed and constructed, the current proposal differs because the hyperthermia system would be specifically designed to interact with the magnetic nanoparticles injected at the tumor site. The proposal exploits the physical similarities between the magnetic nanoparticles currently employed for MPH and those used as superparamagnetic iron oxide (SPIO) contrast agents in MR imaging. The proposal involves the addition of a rotating magnetic field RF hyperthermia source perpendicular to the MRI B0 field which operates in a similar manner to the MRI RF excitation field, B1, but at significantly higher frequency and field strength such that the magnetic nanoparticles are forced to rotate in its presence. This rotation is the source of increases in temperature which are of therapeutic benefit in cancer therapy. For rotating magnetic fields with amplitudes much smaller than B0, the nanoparticles' suspension magnetization rapidly saturates with increasing B0. Therefore, the proposal is best suited to low-field MRI systems when magnetic saturation is incomplete. In addition, careful design of the RF hyperthermia source is required to ensure no physical or RF interference with the B1 field used for MRI excitation. Notwithstanding these caveats, the authors have shown that localized steady-state temperature rises in small spherical tumors of up to 10°C are conceivable with careful selection of the nanoparticle radius and concentration, RF hyperthermia field amplitude and frequency.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URLhttp://onlinelibrary.wiley.com/doi/10.1002/cmr.a.20153/abstract
DOI_LINK
FUNDING_BODY
GRANT_DETAILS